Company News

Sales Rise 2% for Symrise in Q1 2025

The gains were supported by the strength of the group’s diversified, innovation-led portfolio as well as higher volumes across both segments and sustained customer demand.

Author Image

By: Lianna Albrizio

Associate Editor

Symrise AG had a healthy start into the 2025 fiscal year, with organic growth of 4.2% in the first quarter.

Reported sales rose 2.0% to €1.3 billion from €1.292 billion the prior-year quarter. The gains were supported by the strength of the group’s diversified, innovation-led portfolio as well as higher volumes across both segments and sustained customer demand.

“We once again delivered profitable growth despite continued macroeconomic uncertainty,” said Dr. Jean-Yves Parisot, CEO of Symrise AG. “The group’s performance is underpinned by our diversified portfolio and unique global platform. We are capturing growth and enhancing margin quality through focused execution of our ONE Symrise strategy, continuous investments in innovation, and stronger alignment across our businesses. We remain confident in our outlook for the current year and in our ability to deliver profitable above-market growth through 2028. Symrise is well positioned to create sustainable, long-term value for our customers, partners and shareholders.”

Scent & Care

The Scent & Care segment — comprising Symrise’s activities in fragrance applications, aroma chemicals and cosmetic ingredients — recorded organic sales growth of 1.7% in the first quarter. Sales increased slightly to €518 million from €516 million the prior-year quarter. The segment achieved stable development despite a tough comparison against very strong sales of cosmetic ingredients in the prior-year period.

Fragrance

The Fragrance division achieved high-single-digit organic growth, supported by strong momentum in the Fine Fragrances, Consumer Fragrance, and Oral Care business units, given high project vitality in personal care and household applications. Growth continued to be robust in the Latin America, EAME and Asia/Pacific regions.

Cosmetic Ingredients

Sales in the Cosmetic Ingredients division were lower year-over-year due to very high comparables in sunscreen filters. The division remains strategically well positioned with a differentiated product offering — including micro protection, cosmetic actives, botanicals, and sunscreen filters — and is expected to return to superior, above market growth rates going forward.

The Aroma Molecules division also delivered high-single-digit growth supported by strong momentum and robust demand in North America and Asia/Pacific regions.

Symrise Reaffirms Profitability targets for 2025 and 2028

The group reaffirms its financial targets for the current year and its mid-term ambitions through 2028, which are underpinned by an unwavering focus on executing the ONE Symrise strategy.
Symrise is leveraging the strength of its resilient and diversified portfolio, industry-leading R&D, and close customer partnerships to manage complexity and drive scalable, profitable growth. Its international footprint and balanced end-market exposure positions the Group to nimbly manage external pressures, including the impact of evolving tariff regimes. Where needed, price adjustments are being implemented in close coordination with customers to offset input cost.

Symrise said it expects to grow above the anticipated annual market growth rate of approximately 3% to 4%. The group reaffirms the 2025 guidance to achieve an organic growth of 5% to 7%, an EBITDA margin of around 21% and a business free cash flow of around 14% (as percentage of sales).

The group also reaffirms 2028 mid-term targets, aiming for an organic growth of 5% to 7% (CAGR) and an EBITDA margin in the range of 21% to 23%. Disciplined capital allocation and operating efficiency will continue supporting business free cash flow of more than 14%.

ONE Symrise strategy

The company’s ONE Symrise strategy is underpinned by three pillars of growth, efficiency and portfolio management. During the first quarter, it further progressed its strategic execution across all three pillars, including a focus on building a strong portfolio to meet the market trends in fast growing and profitable areas.

As such, during the past months, the group executed a strategic assessment of the existing footprint of the chemicals production activities. That includes exploring strategic options for terpene ingredients, with further updates to be provided in the coming quarters.

Keep Up With Our Content. Subscribe To Happi Newsletters